Core Scientific, Inc. (CORZ) Cash Flow Statement
Core Scientific, Inc. (CORZ) generated $520.2M of operating cash flow over the twelve months to 2026-06-30, spent $1.7B on capital expenditure and had free cash flow of -$1.2B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CORZCore Scientific, Inc.Follow CORZ — free
—
Price chart with a free account
- Market cap
- 4.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Operating cash flow | 0.21 | 0.07 | 0.04 | 0.28 | 0.52 | |
| Capital expenditure | 0.38 | 0.02 | 0.09 | 0.73 | -1.71 | |
| Free cash flow | -0.18 | 0.05 | -0.05 | -0.45 | -1.19 | |
| Share repurchases | 0.03 | 0.00 | 0.00 | — | — | |
| Stock-based compensation | 0.18 | 0.06 | 0.05 | 0.10 | — |
USD billions · SEC XBRL
Core Scientific, Inc. — questions
- What is Core Scientific, Inc.'s operating cash flow?
- $520.2M over the twelve months to 2026-06-30.
- How much does Core Scientific, Inc. spend on capital expenditure?
- $1.7B over the twelve months to 2026-06-30.
- What is Core Scientific, Inc.'s free cash flow?
- -$1.2B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Core Scientific, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.